On November 14, the University broke ground on the new academic and science building at 20 Somerset. President James McCarthy, Mayor Thomas M. Menino and other dignitaries were on hand for the ceremony.
- View a Facebook photo gallery of the groundbreaking event
- Read a full recap of the groundbreaking event
- Read Boston Globe coverage of the ceremony
What Students Are Saying
"The timing of the new building couldn't be better, with four floors dedicated to the sciences. I'm looking forward to the next few years of learning as much as I can with the newest technological tools available.” –Katelyn Monti, Freshman, Radiation Science
Why science, why here?
Because Massachusetts is where the jobs are.
The relationship between the science industry and universities like Suffolk is a mutually beneficial one: The sciences rely on us for research and talented workers, while our graduates rely on those organizations for jobs.
Massachusetts leads the nation in biotechnology research & development employment, with 27,883 jobs in 2012.
From 2001 to 2011, Massachusetts saw a 127.3 percent increase in life sciences employment, nearly 16 percent better than the national average.
Since 2001, no industry has grown more in Massachusetts than life sciences, which boasts a 27.3 percent increase in employment. While Massachusetts has the fifth-most life sciences jobs, its growth far outpaces that of its chief rival states.
Take That to the Bank
In 2012, Massachusetts companies received 21 percent ($838 million) of all U.S. venture capital biotech investment.
The most-funded hospital in the nation (almost $353 million from the NIH in 2012) is Massachusetts General Hospital, the closest hospital to Suffolk.
Discovery Happens Here
Along with San Francisco, Boston hosts the largest concentration of biotech activity in the world. All of the world’s top 10 biopharmaceutical firms maintain facilities here, along with over 500 other biopharma companies and more than 400 medical device makers.
Five of the top six (and nine of the top 18) NIH-funded research hospitals are in Massachusetts.
Massachusetts accounts for 11.3 percent of the U.S.-based drug development pipeline. Massachusetts-headquartered companies account for 5 percent of the global biologics pipeline.
Show Me the Money
The estimated average salary in the biopharma industry is $115,290, 89 percent higher than the estimated state average salary of $60,901.
Life sciences workers with a bachelor’s degree earned an average of $92,033 annually from 2006 to 2010. That’s more than $30,000 more than those with an associate’s degree and more than double those with no college degree.
Statistics collected from Massachusetts Biotechnology Council and Massachusetts Life Sciences Center. Sources:
US Bureau of Labor Statistics’ Quarterly Census of Employment & Wage (QCEW) data
2013 PricewaterhouseCoopers, National Venture Capital Association, MoneyTree Report, Historical Trend Data
US Bureau of Labor Statistics’ QCEW data
US Bureau of Labor Statistics
Dukakis Center for Urban and Regional Policy analysis of American census data